Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. X4 Pharmaceuticals Inc shares valued at $46,347 were sold by Mostafa Adam S. on Mar 11 ’24. At $0.88 per share, Mostafa Adam S. sold 52,500 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Ragan Paula sold 49,678 shares, netting a total of over 43,856 in proceeds. Following the sale of shares at $0.88 each, the insider now holds 765,068 shares.
Before that, DiBiase Mary had sold 15,409 shares from its account. In a trade valued at $13,591, the Chief Operating Officer traded X4 Pharmaceuticals Inc shares for $0.88 each. Upon closing the transaction, the insider’s holdings decreased to 15,409 shares, worth approximately $0.26 million.
As published in a research note from B. Riley Securities on December 12, 2023, X4 Pharmaceuticals Inc [XFOR] has been rated down from a Buy to a Neutral and the price target has been revised to $1 from $3. As of December 22, 2022, Cantor Fitzgerald has initiated its “an Overweight” rating for XFOR. Earlier on December 12, 2022, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for XFOR stock.
Analyzing XFOR Stock Performance
During the last five days, there has been a drop of approximately -6.21%. Over the course of the year, X4 Pharmaceuticals Inc shares have jumped approximately 7.35%. Shares of the company reached a 52-week high of $1.6000 on 04/03/24 and a 52-week low of $0.7004 on 01/25/24. A 50-day SMA is recorded $1.1687, while a 200-day SMA reached $0.9865. Nevertheless, trading volume fell to 1.47 million shares from 0.63 million shares the previous day.
Support And Resistance Levels for X4 Pharmaceuticals Inc (XFOR)
According to the 24-hour chart, there is a support level at 0.8659, which, if violated, would cause prices to drop to 0.8316. In the upper region, resistance lies at 0.9374. The next price resistance is at 0.9746. RSI (Relative Strength Index) is 35.13 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0903, which suggests the price will decrease in the coming days. Percent R is at 88.21%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
